Blend Labs, Inc. (NYSE:BLND) Insider Sells $18,559.39 in Stock

Blend Labs, Inc. (NYSE:BLND) insider Oxana Tkach sold 4,247 shares of the company’s stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $4.37, for a total value of $18,559.39. Following the completion of the transaction, the insider now owns 84,430 shares of the company’s stock, valued at $368,959.10. The trade was a 4.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Oxana Tkach also recently made the following trade(s):

• On Monday, November 25th, Oxana Tkach sold 18,324 shares of Blend Labs stock. The stock was sold at an average price of $5.18, for a total transaction of $94,918.32.

Blend Labs Stock Up 0.2 %

BLND traded up $0.01 on Monday, hitting $4.41. The company had a trading volume of 3,004,674 shares, compared to its average volume of 2,395,239. The business’s fifty day simple moving average is $4.44 and its 200 day simple moving average is $3.62. Blend Labs, Inc. has a 12-month low of $2.08 and a 12-month high of $5.53. The company has a market cap of $1.13 billion, a PE ratio of -12.97 and a beta of 1.33.

Analyst Ratings Changes

Several equities analysts recently weighed in on BLND shares. Wells Fargo & Company raised their target price on shares of Blend Labs from $4.50 to $6.50 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Canaccord Genuity Group restated a “buy” rating and set a $5.75 price objective on shares of Blend Labs in a research report on Friday. UBS Group boosted their target price on Blend Labs from $3.00 to $4.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 23rd. Keefe, Bruyette & Woods increased their price target on Blend Labs from $3.25 to $3.85 and gave the company a “market perform” rating in a research note on Thursday, November 7th. Finally, JMP Securities assumed coverage on Blend Labs in a research note on Wednesday, December 18th. They issued an “outperform” rating and a $7.00 price objective on the stock. Two analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $5.11.

Institutional Investors Weigh In On Blend Labs

Several institutional investors have recently modified their holdings of BLND. Advantage Alpha Capital Partners LP bought a new stake in shares of Blend Labs in the 3rd quarter worth about $3,253,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in Blend Labs in the 3rd quarter worth about $676,000. SG Americas Securities LLC bought a new stake in Blend Labs in the third quarter worth about $660,000. Fullcircle Wealth LLC purchased a new position in shares of Blend Labs during the third quarter valued at approximately $508,000. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Blend Labs by 7.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,643,051 shares of the company’s stock valued at $6,161,000 after buying an additional 120,152 shares during the last quarter. 52.56% of the stock is owned by institutional investors.

About Blend Labs

Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.